Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

Ending clinical trials with no warning can put patients at risk.

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even ...

The clinical trial, based on more than three decades of ... 12 months and beyond to determine the safety of the procedure and monitor for any improvements in Parkinson's disease.

A clinical trial conducted by  Dartmouth researchers has shown the potential of a generative AI-powered therapy chatbot ...

Dartmouth researchers conducted the first clinical trial of an AI-powered therapy chatbot and found that, on average, people ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

The clinical trial provided the participants randomly ... through standardized questionnaires clinicians use to detect and monitor each condition. The team did a second assessment after another ...

A recently launched Phase 1 clinical trial at Mass General Brigham is examining ... beyond to determine the safety of the procedure and monitor for any improvements in Parkinson’s disease.